These are press releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Jun 25, 2020- Twenty-five percent absolute survival benefit at 5 years for patients receiving stereotactic ablative radiotherapy to all metastatic lesions
-
May 21, 2020New features help clients safeguard care teams and cancer patients, proactively communicate, and ensure access to care
-
May 18, 2020First member from Southeast Asia, Proton Therapy Pte., Ltd., joins Varian's FlashForward Consortium
-
May 7, 2020The National University Cancer Institute, Singapore, partners with Varian to extend advanced oncology solutions to cancer patients
-
Mar 10, 2020First treatments completed in Australia and The Netherlands
-
Feb 27, 2020
-
Feb 11, 2020Ethos represents a new chapter in democratized cancer care
-
Nov 25, 2019
-
Nov 6, 2019Key Highlights
-
Oct 23, 2019Varian proton therapy systems to now be installed in two Penn Medicine centers
-
Sep 16, 2019Francis R. Facchini, M.D., FSIR, fills new role for interventional oncology globally
-
Sep 16, 2019Company Ranked Highest in Eight Key Performance Areas and Net Promotor Score
-
Aug 21, 2019
-
Aug 21, 2019
-
Aug 19, 2019
-
Jul 9, 2019Her Royal Highness Princess Maha Chakri Sirindhorn Presided Over Rigging Ceremony
-
Jul 2, 2019Company to acquire assets from Boston Scientific to expand embolic bead offering
-
Jun 26, 2019Collaboration with Tennessee Oncology Aims to Improve Access to Care Across Rural Patient Populations
-
Jun 10, 2019Company acquires Endocare and Alicon to add cryoablation and microwave ablation therapies and embolic beads to cancer care solutions portfolio
-
May 20, 2019Advances Varian Toward Being a Broad-Based Cancer Solutions Company; Updates Annual Guidance
-
May 9, 2019Company Adds Technology for Cardiac Radioablation to Its Radiation Medicine Portfolio
-
May 7, 2019
-
Apr 24, 2019Raises Revenue Guidance for Fiscal Year 2019
-
Apr 3, 2019Flash therapy preclinical results presented at AACR